Biosimulation Market to Reach a Capital Expenditure of USD 10.1 in 2032 | CAGR of 13.7% New York, April 25, 2023 (GLOBE NEWSWIRE) -- As per the latest finding of Market.us, Biosimulation Market Revenue is expected to be USD 2.9 by the end of 2022. In the long term, the market is...